Holsigrip

Holsigrip is an oral medication that combines pseudoephedrine hydrochloride and paracetamol. It is formulated to provide relief from nasal congestion, headache, fever, and other common cold and flu symptoms. The product is marketed in the European Union and belongs to the sympathomimetic decongestant and analgesic combination class. Each tablet delivers a balanced dose of the two active ingredients, aiming to reduce swelling of nasal passages while alleviating pain and fever.

Holsigrip is indicated for the temporary relief of several symptoms associated with upper respiratory infections and flu-like illnesses.

- Nasal congestion caused by swollen nasal mucosa during colds or allergies. - Headache and mild to moderate pain such as sinus pressure or muscle aches. - Fever associated with viral infections or flu. - General discomfort, chills, and body aches accompanying cold and flu. - Relief of sinus pressure and ear fullness due to congestion. - Sore throat discomfort when associated with congestion.

Like most combination cold medicines, Holsigrip may cause a range of side effects.

Common: - Dry mouth or throat irritation. - Mild nausea or stomach discomfort. - Drowsiness or difficulty sleeping. - Slight increase in heart rate or palpitations. - Tremor or shakiness. - Mild headache. - Insomnia or restlessness. - Blurred vision. - Feeling of fullness in ears. - Nasal dryness. - Loss of appetite. - Sweating.

Serious: - Severe allergic reaction with rash, swelling, or difficulty breathing. - High blood pressure spikes. - Liver function abnormalities indicated by jaundice or dark urine. - Chest pain or tightness. - Persistent vomiting. - Seizures or convulsions. - Kidney impairment signs such as reduced urine output. - Unexplained bruising or bleeding. - Severe dizziness leading to fainting.

Before using Holsigrip, certain health considerations should be reviewed to ensure safe use.

- Avoid use if you have uncontrolled hypertension or severe heart disease. - Consult a healthcare professional if you are pregnant, breastfeeding, or planning pregnancy. - Do not exceed the recommended daily amount of paracetamol from all sources. - Use caution in patients with liver disease, kidney impairment, or a history of alcohol misuse. - Individuals with diabetes should monitor blood glucose, as pseudoephedrine may affect levels. - Patients with thyroid disorders or glaucoma should discuss suitability with a doctor. - Discontinue use if symptoms persist beyond a few days or worsen.

Holsgirip can interact with other medicines, affecting their effectiveness or increasing risk of adverse effects.

Avoid: - Monoamine oxidase inhibitors (MAOIs) or recent MAOI therapy, due to risk of hypertensive crisis. - Other decongestants containing pseudoephedrine, phenylephrine, or ephedrine, which may cause excess stimulation. - Additional paracetamol‑containing products, to prevent overdose.

Use with caution: - Antihypertensive drugs, as pseudoephedrine may reduce their blood pressure‑lowering effect. - Anticoagulants such as warfarin, because paracetamol can alter INR values. - Certain antidepressants (SSRIs, SNRIs) that may increase serotonergic activity. - Beta‑blockers, which may blunt the cardiovascular response to pseudoephedrine.